Michael C. Hewitt

Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria

Louis Schofield, Michael C. Hewitt, Krystal J. Evans et al. · Nature · 2002 · 485 citations

Vaccination, Synthetic Gpi, Vaccine Target +8

BRD4 is an atypical kinase that phosphorylates Serine2 of the RNA Polymerase II carboxy-terminal domain

Ballachanda N. Devaiah, Brian A. Lewis, Natasha Cherman et al. · Proceedings of the National Academy of Sciences · 2012 · 375 citations · Full text

Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials

Brian K. Albrecht, Victor Gehling, Michael C. Hewitt et al. · Journal of Medicinal Chemistry · 2016 · 214 citations · Full text

Immunology, Pharmacotherapy, Tumor Biology +22

Rapid Synthesis of a Glycosylphosphatidylinositol-Based Malaria Vaccine Using Automated Solid-Phase Oligosaccharide Synthesis

Michael C. Hewitt, Daniel A. Snyder, Peter H. Seeberger · Journal of the American Chemical Society · 2002 · 134 citations

Bioorganic Chemistry, Malaria, Glycobiology +21

Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains

Terry D. Crawford, Vickie Tsui, E. Megan Flynn et al. · Journal of Medicinal Chemistry · 2016 · 117 citations · Full text

Molecular Biology, Chemical Biology, Pharmaceutical Chemistry +17